Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trial
紫杉醇纳米粒联合卡多尼利单抗(AK104)作为晚期胃癌二线治疗:一项II期前瞻性、多中心、单臂临床试验方案
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1519545
Wei, Jing; Zhang, Pengfei; Hu, Qiancheng; Cheng, Xiaolong; Shen, Chaoyong; Chen, Zhixin; Zhuang, Wen; Yin, Yuan; Zhang, Bo; Gou, Hongfeng; Yang, Kun; Bi, Feng; Liu, Ming